SOPHARMA AD: Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

/

2026

Date of issue:

2026-01-09

Short name of the issuer

SOPHARMA AD

Subject

Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, January 9, 2026 – “Sopharma” AD, with its registered office and registered office in Sofia, 16 Iliensko Shose Str., UIC831902088, supplements the announcements under art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively, published on January 9, 2026 with current reports № 6, № 8 and № 10 as follows:

“The rights are issued in favor of the shareholders, entered as such in the register of “Central Depository” AD no later than 5 business days after the date of publication of the announcement under Art. 89t, para. 1 of the LPOS on the website of the Issuer and on the website of the Investment Intermediary “Sofia International Securities” AD.

The current shareholders acquire the rights free of charge. All other investors may purchase rights through a transaction on the main market organized by the “Bulgarian Stock Exchange” AD, a rights segment during the period for transferring the rights or at the public auction organized by the “Bulgarian Stock Exchange” AD for the unexercised rights, after the expiration of the period for transferring the rights.”

Annexes

File

Description

SFA_89t_ad_w_09012026_espi.pdf

Supplement to announcements under Art. 89t of the LPOS regarding the initial public offering of an issue of warrants with an exercise period of up to 3, 5 and 7 years, respectively

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

2026-01-09

Ognian Ivanov Donev

Executive Director